Russian drug law hinders clinical trials – Nature.com
“It's one of the main flaws of the Russian regulatory system under the new law,” says Sergei Lomakin, a senior associate at the Moscow office of the international law firm Baker & McKenzie. “The system leads to a bigger number of rejections than one ...
Subscribe to LegalLaw247.Com Newsletter